Economic Analysis of Initial HIV Treatment: Efavirenz- versus Indinavir-Containing Triple Therapy

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.1, 2001-01, pp. : 95-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efavirenz-containing regimen superior in advanced HIV

Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Efavirenz-based therapy a winner for HIV-1 infections

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Efavirenz-containing regimens superior in HIV-1 infection?

Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Triple nucleoside analogue antiretroviral therapy: expanding the treatment approaches for management of HIV infection

By Moyle G.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1147-1155

Informa Healthcare

Access to resources Recommend Favorite

Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients

By Röshammar Daniel

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 6, 2011-12 ,pp. : 727-742

Springer Publishing Company

Access to resources Recommend Favorite